Description
Arsenam 10 mg contains Arsenic Trioxide, a potent antineoplastic agent primarily used in the treatment of acute promyelocytic leukemia (APL), especially in patients who are relapsed or refractory to other therapies such as all-trans retinoic acid (ATRA).
🔬 Mechanism of Action
Arsenic Trioxide targets the PML-RARA fusion protein, a hallmark of APL. As a result, it:
- Induces differentiation of immature leukemia cells into mature cells
- Promotes apoptosis (programmed cell death)
- Inhibits proliferation of leukemic cells
This dual mechanism makes it highly effective in treating APL.
💊 Indications
Arsenam 10 mg is indicated for:
- Relapsed or refractory Acute Promyelocytic Leukemia (APL)
- Newly diagnosed APL (in combination with ATRA as per treatment protocols)
📌 Key Features
- Strength: 10 mg
- Dosage Form: Injection for intravenous infusion
- Therapeutic Class: Antineoplastic Agent / Differentiation Therapy
- Administration: Given via IV infusion under strict medical supervision
- Monitoring: ECG monitoring (QT interval), electrolytes, and liver function tests required
⚕️ Benefits
- Highly effective in APL treatment
- Promotes remission through targeted differentiation
- Can be combined with ATRA for improved outcomes
- Established therapy in modern leukemia protocols
⚠️ Precautions
- Risk of QT prolongation and cardiac arrhythmias
- Electrolyte imbalance must be corrected before treatment
- Risk of differentiation syndrome (APL syndrome)
- Requires close monitoring during therapy
- Use strictly under hematologist/oncologist supervision
Arsenam 10 mg (Arsenic Trioxide Injection) is a life-saving targeted therapy for acute promyelocytic leukemia, offering high remission rates and improved survival outcomes when administered under specialized medical care.
